Accupril and Vantin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Accupril and Vantin. Common interactions include cough among females and renal failure among males.

The phase IV clinical study analyzes what interactions people who take Accupril and Vantin have. It is created by eHealthMe based on reports of 7 people who take Accupril and Vantin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 22, 2022

7 people who take Accupril and Vantin together, and have interactions are studied.


What is Accupril?

Accupril has active ingredients of quinapril hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 13,222 Accupril users for its effectiveness, alternative drugs and more.

What is Vantin?

Vantin has active ingredients of cefpodoxime proxetil. It is often used in sinusitis. eHealthMe is studying from 764 Vantin users for its effectiveness, alternative drugs and more.

Number of Accupril and Vantin reports submitted per year:

Accupril and Vantin drug interactions.

Common Accupril and Vantin drug interactions by gender *:

female:

  1. Cough
  2. Diabetes mellitus inadequate control
  3. Diarrhoea
  4. Dysuria
  5. Haemoptysis
  6. Heart rate decreased
  7. Impaired gastric emptying
  8. Infusion related reaction
  9. Lung infiltration
  10. Lupus pneumonitis

male:

  1. Renal failure
  2. Anhedonia
  3. Renal injury
  4. Stress
  5. Abasia
  6. Activities of daily living impaired
  7. Agitation
  8. Aneurysm
  9. Aortic aneurysm
  10. Aortic valve sclerosis

Common Accupril and Vantin drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Abdominal pain
  2. Blood bicarbonate decreased
  3. Diabetes mellitus inadequate control
  4. Diarrhoea
  5. Dyspnoea
  6. Dysuria
  7. Haemoptysis
  8. Heart rate decreased
  9. Impaired gastric emptying
  10. Infusion related reaction

50-59:

n/a

60+:

  1. Anhedonia
  2. Anxiety
  3. Renal injury
  4. Stress
  5. Appetite decreased
  6. Cardiac failure congestive
  7. Carotid artery thrombosis
  8. Chronic obstructive airways disease
  9. Cough
  10. Dermatitis

* Approximation only. Some reports may have incomplete information.

Do you take Accupril and Vantin?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Accupril and Vantin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Accupril interactions:

Browse all interactions between Accupril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on quinapril hydrochloride and cefpodoxime proxetil (the active ingredients of Accupril and Vantin, respectively), and Accupril and Vantin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Accupril and Vantin.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: